Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This prospective multicenter, double blind study will evaluate the efficacy and safety of
aliskiren versus ramipril in patients with moderate systolic essential hypertension.